Bioness Medical Acquires Assets and Business of Harmonic Bionics

Bioventus Acquires Bioness, Inc.

March 30, 2021

Medical Devices

Bioventus Inc. acquired Bioness, Inc. for $45 million in up-front consideration plus up to $65 million of contingent consideration, making Bioness a wholly‑owned subsidiary. The acquisition expands Bioventus' rehabilitation and neuromodulation product portfolio and R&D pipeline, and is expected to be accretive to revenue by leveraging Bioventus' global commercial infrastructure.

Accelmed Partners Acquires Bioventus' Bioness Advanced Rehabilitation Business

October 1, 2024

Medical Devices

Bioventus has signed a definitive agreement to sell the Advanced Rehabilitation business of its subsidiary Bioness to private equity firm Accelmed Partners for total cash consideration of $45 million (including up to $20 million in earn-outs). The divestiture reduces Bioventus' annual revenue by about $50 million and allows Bioventus to focus on its core business while Accelmed plans to invest in and expand the Bioness rehabilitation product line.

Boston Scientific Acquires Axonics, Inc.

November 15, 2024

Medical Devices

Boston Scientific Corporation agreed to and completed the acquisition of Axonics, Inc., a publicly traded medical technology company focused on sacral neuromodulation and urology devices, for $71 per share (approximately $3.7 billion equity value). The deal expands Boston Scientific’s urology portfolio by adding Axonics’ SNM therapy products and related technologies, expected to be accretive to its Urology business over time.

Mirion Technologies Acquires Biodex Medical Systems

September 1, 2020

Medical Devices

Mirion Technologies, a San Ramon-based, PE-backed provider of radiation detection and measurement solutions, acquired Biodex Medical Systems, Inc. effective September 1, 2020. Biodex, a manufacturer of nuclear medicine instruments, medical imaging equipment and rehabilitation systems headquartered in Shirley, New York, will expand Mirion's medical device and imaging capabilities as part of Mirion's strategic plan to grow its medical business.

OMERS Private Equity Acquires Majority Stake in Bionic

July 20, 2022

Professional Services

OMERS Private Equity has signed a definitive agreement to acquire a majority stake in Bionic from ECI Partners and the company's founders; ECI and the founders will reinvest alongside OMERS and the Bionic management team. OMERS will provide capital and buy-and-build expertise to accelerate Bionic's organic growth and M&A-driven expansion in the UK and internationally; financial terms were not disclosed and the deal is expected to close by Q3.

Accenture Acquires Bionic

June 29, 2021

Consulting

Accenture acquired Bionic, a New York–based growth and innovation consultancy known for its proprietary GrowthOS platform, to bolster Accenture Interactive's Growth and Business Design practice. Financial terms were not disclosed; Bionic's team of roughly 40 entrepreneurs and designers will join Accenture to expand its experience-led growth capabilities.